Leap Therapeutics GAAP EPS of -$0.46 Beats Analysts' Estimates by $0.10
Monday, 18 March 2024, 11:10
Leap Therapeutics GAAP EPS Result
Leap Therapeutics reported a GAAP EPS of -$0.46, surpassing analysts' expectations by $0.10. The company's financial performance highlights its resilience and strategic decision-making in a challenging market environment.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.